Search clinical trials for: Humalog® Mix 75/25

Total 439 results

Biodel

Suspended

A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes

Diabetes Mellitus

United States
Eli Lilly and Company

Completed

The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) (IOOV)

Diabetes Mellitus, Type 2

United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
Adocia

Completed

A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Biodel

Completed

BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance

Diabetes Mellitus

United States
Biodel

Completed

Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500

Type 2 Diabetes Mellitus

United States
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects

Clamp Study

Russian Federation
NanoFUSE Biologics, LLC

Unknown

NanoFUSE® PL Gutter PMCF

Degenerative Disc Disease
Yanbing Li

Unknown

A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy

Type 2 Diabetes Mellitus | Peritoneal Dialysis

China
Eli Lilly and Company

Completed

24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine

Type 2 Diabetes

United States
Wockhardt

Withdrawn

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects

Bioequivalence in Healthy Subjects

United States
Eli Lilly and Company

Completed

Lispro Mix 25 vs. Glargine in Type 2 Diabetics (IOOL)

Diabetes Mellitus Type 2

Mexico
Pfizer

Completed

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

Migraine

Japan
EMD Serono
Merck KGaA, Darmstadt, Germany

Terminated

Atacicept in Multiple Sclerosis Extension Study, Phase II (ATAMS ext)

Relapsing Multiple Sclerosis

Sweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles

Pregnancy

Spain
Alto Neuroscience

Recruiting

PD, PK, and Safety of ALTO-203 in Patients With MDD

Anhedonia | Major Depressive Disorder

United States
Apnimed

Completed

Trial of AD036 in Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Eli Lilly and Company

Completed

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

Diabetes Mellitus, Type 2

Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
PHARMENTERPRISES LLC

Not yet recruiting

Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis

Cystitis

Russian Federation
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

Efficacy and Safety of Atacicept in IgA Nephropathy

IgA Nephropathy

United States, Japan, United Kingdom
Eli Lilly and Company

Completed

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) (S019)

Diabetes Mellitus, Type 2

Croatia, Poland, Romania, South Africa, Turkey
Adocia

Completed

A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Cinclus Pharma Holding AB

Active, not recruiting

Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects

GERD

Slovenia
Eli Lilly and Company

Completed

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX) (IOOX)

Diabetes Mellitus, Type 2

Australia, Russian Federation, Spain, Mexico, Canada, France, Korea, Republic of
Duke University
The Derfner Foundation

Completed

Inspiratory Muscle Rehabilitation in Children With Obesity (BREATHE Fit)

Pediatric Obesity

United States
University of Texas Southwestern Medical Center

Recruiting

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial) (PEAC)

Anesthesia | Anesthesia; Reaction | Anesthesia Complication | Anesthesia; Adverse Effect | Propofol Adverse Reaction | Etomidate Adverse Reaction

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Hypertension

United States, Belgium, Hungary, Turkey, Guatemala, Slovakia, Germany, Puerto Rico, Poland
The First Hospital of Jilin University

Not yet recruiting

Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis

Acute Respiratory Distress Syndrome
W.L.Gore & Associates

Completed

Evaluation of the 25 Centimeter (cm) GORE® VIABAHN® Endoprosthesis

Peripheral Vascular Diseases
Gan and Lee Pharmaceuticals, USA

Completed

PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males

Diabetes Mellitus

Germany
University of Bern
Forel Clinic; Clinic Südhang; Psychiatric Center Muensingen

Completed

Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders (INTRA)

Alcohol Dependence

Switzerland
Geropharm

Completed

Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus

Russian Federation
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers

Healthy

Germany
Arkansas Children's Hospital Research Institute

Completed

Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy (ktpump)

Diabetes Mellitus

United States
Alkahest, Inc.

Completed

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

End-Stage Renal Disease

United States
Eli Lilly and Company

Completed

A Study for Patients With Diabetes Mellitus (IOPA) (IOPA)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Duke University
National Institutes of Health (NIH)

Not yet recruiting

Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA) (MICA)

Obesity | Pediatric Obesity | Asthma in Children | Pediatric Asthma

United States
Laboratoires Innothera
University Hospital, Grenoble; Floralis

Completed

Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome (CELEST)

Deep Vein Thrombosis | Post-thrombotic Syndrome

France
Kaplan Medical Center

Completed

Prebiotics in Patients With Non-alcoholic Liver Disease

Metabolic Syndrome | Non-alcoholic Fatty Liver Disease

Israel
Adocia

Completed

A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Sansum Diabetes Research Institute
Eli Lilly and Company

Completed

Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes

Gestational Diabetes Mellitus
Le Club Mousse

Completed

Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein

Venous Disease
University of North Carolina, Chapel Hill
Terumo Medical Corporation

Terminated

Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia

Prostatic Hyperplasia | BPH | Enlarged Prostate (BPH)

United States
Orthomedico Inc.
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

Completed

The Effect of Oral Hyaluronic Acid (UltraHA®) on the Knee Function

Healthy Japanese Subjects

Japan
Bioverativ Therapeutics Inc.
Swedish Orphan Biovitrum

Completed

Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B (Kids B-LONG)

Hemophilia B

United States, United Kingdom, South Africa, Netherlands, Ireland, Australia
Adocia

Completed

Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Shire

Completed

A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

Crohn's Disease | Ulcerative Colitis

Spain, United States, Korea, Republic of, Lebanon, Australia, Russian Federation, Romania, Hungary, Portugal, Israel, Italy, Turkey, Croatia, Belgium, Bulgaria, Germany, Netherlands, Poland, New Zealand, Argentina, United Kingdom, Greec... and more
Adocia

Completed

A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany
Vertex Pharmaceuticals Incorporated
Cystic Fibrosis Foundation

Completed

Safety Study of Ivacaftor in Subjects With Cystic Fibrosis

Cystic Fibrosis

United States, Canada, Germany
Sanofi

Completed

Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment

Diabetes Mellitus, Type 2

United States
iX Biopharma Ltd.

Completed

Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain

Acute Pain | Bunion | Abdominoplasty

United States

Search clinical trials for: Humalog® Mix 75/25

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations